A Systematic Review of Clinical Practice Guidelines for Neonatal Abstinence Syndrome [PDF]
Children, 2023 Background: The prevalence of neonatal abstinence syndrome is increasing, but the number and quality of clinical practice guidelines available are unknown.
Zoe Wei +8 more
doaj +2 more sources
The Genomics of Neonatal Abstinence Syndrome [PDF]
Frontiers in Pediatrics, 2017 Significant variability has been observed in the development and severity of neonatal abstinence syndrome (NAS) among neonates exposed to prenatal opioids.
F. Sessions Cole +2 more
doaj +4 more sources
Mixed-Methods Evaluation of Massachusetts’ Neonatal Abstinence Syndrome Surveillance System, 2020–2022 [PDF]
AJPM FocusIntroduction: The Massachusetts Department of Public Health established neonatal abstinence syndrome surveillance as an active, state-wide, population-based system using the Council of State and Territorial Epidemiologists (Tier 1) neonatal abstinence ...
Alyssa M. Pochkar, MPH +3 more
doaj +2 more sources
Neonatal Abstinence Syndrome: Prevention, Management and Outcomes: From Birth to Adulthood [PDF]
Children, 2022 Neonatal abstinence syndrome (NAS), or—when specifically focused on opioids—neonatal opioid withdrawal syndrome (NOWS) is a withdrawal syndrome in neonates after birth causally related to the in utero exposure to drugs of dependence, and the subsequent ...
Karel Allegaert, Ju-Lee Oei
doaj +2 more sources
A review of the genomics of neonatal abstinence syndrome [PDF]
Frontiers in Genetics, 2023 Neonatal abstinence syndrome (NAS) is a constellation of signs of withdrawal occurring after birth following in utero exposure to licit or illicit opioids.
Elizabeth Yen +7 more
doaj +2 more sources
Clinical and demographic predictors of the need for pharmacotherapy in neonatal abstinence syndrome [PDF]
Frontiers in PediatricsObjectiveDevelopment and validation of a clinical prediction model for receipt of pharmacotherapy for Neonatal Abstinence Syndrome (NAS).Study designData from three cohorts included in- utero opioid exposed neonates ≥37 weeks gestation.
Shawana Bibi +7 more
doaj +2 more sources
Gestational Age Alters Assessment of Neonatal Abstinence Syndrome [PDF]
Pediatric Reports, 2022 Neonatal abstinence syndrome (NAS) due to maternal opioid use affects both term and preterm infants; however, the relationship between gestational age and clinical symptomatology is still poorly understood.
Sasha Amiri, Jayasree Nair
doaj +2 more sources
Improving the Assessment of Neonatal Abstinence Syndrome (NAS) [PDF]
Children, 2021 Neonatal Abstinence Syndrome (NAS) is a public health problem of epidemic proportions. The Finnegan Neonatal Abstinence Scoring System (FNASS) is the tool most widely used to evaluate NAS.
Claire A. Chin Foo +4 more
doaj +2 more sources
Comparison of the effect of phenobarbital & levetiracetam in the treatment of neonatal abstinence syndrome (NAS) as adjuvant treatment in neonates admitted to the neonatal intensive care unit: a randomized clinical trial [PDF]
BMC Pregnancy and ChildbirthBackground Infants who are born from mothers with substance use disorder might suffer from neonatal abstinence syndrome (NAS) and need treatment with medicines.
Zahra Jamali +5 more
doaj +2 more sources
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention [PDF]
BMC Health Services Research, 2023 Background Neonatal Abstinence Syndrome (NAS), a problem common in newborns exposed to substances in-utero, is an emerging health concern. In traditional models of care, infants with NAS are routinely separated from their mothers and admitted to the ...
Osnat Wine +10 more
doaj +2 more sources